Status:
COMPLETED
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.
Lead Sponsor:
Ospedale Sandro Pertini, Roma
Conditions:
Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aloe vera is used for the treatment of inflammatory bowel disease (IBD), but no data are present in regard the gel formulation as topical therapy in active ulcerative colitis.
Detailed Description
44 ulcerative colitis (UC) patients were enrolled and randomly allocated to treatment for 4 weeks with oral mesalazine (800 mg three times daily) and enema (60 ml aloe vera gel) 1/day (n = 22, Group A...
Eligibility Criteria
Inclusion
- age over 18 years, mild to moderate active ulcerative proctosigmoiditis, diagnosed for the first time and no therapy started before. The maximum extension of the disease was accepted of 40-60 cm from the anal verge or distal disease.
Exclusion
- an extension of disease above the sigma, renal impairment, pregnancy, lactation or established low compliance
Key Trial Info
Start Date :
March 10 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2010
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04753775
Start Date
March 10 2010
End Date
May 10 2010
Last Update
February 15 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.